tradingkey.logo

Bausch + Lomb Corp

BLCO
View Detailed Chart

13.500USD

-0.120-0.88%
Close 08/01, 16:00ETQuotes delayed by 15 min
4.78BMarket Cap
LossP/E TTM

Bausch + Lomb Corp

13.500

-0.120-0.88%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.88%

5 Days

-5.73%

1 Month

-2.74%

6 Months

-22.64%

Year to Date

-25.25%

1 Year

-17.33%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 13 analysts
HOLD
Current Rating
15.164
Target Price
12.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Bausch + Lomb Corp
BLCO
13
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(2)
Buy(2)
Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.257
Neutral
RSI(14)
47.842
Neutral
STOCH(KDJ)(9,3,3)
26.310
Sell
ATR(14)
0.528
High Vlolatility
CCI(14)
-157.948
Sell
Williams %R
79.902
Sell
TRIX(12,20)
0.417
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
13.986
Sell
MA10
14.069
Sell
MA20
14.004
Sell
MA50
12.834
Buy
MA100
12.972
Buy
MA200
15.656
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Ticker SymbolBLCO
CompanyBausch + Lomb Corp
CEOMr. Brenton L. (Brent) Saunders, J.D.
Websitehttps://ir.bausch.com/
KeyAI